Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Review of the Literature on Different Aspects of Testosterone Therapy for Women Publisher



Abedi AR1 ; Allameh F2 ; Hosseini S3 ; Ghahestani SM4 ; Tadayon N5
Authors

Source: Journal of Iranian Medical Council Published:2023


Abstract

Background: Testosterone is necessary for general well- being, mental and physical health. Testosterone level decreases with age. Women also benefit from testosterone therapy. Testosterone therapy improves mood, mental and physical health. Testosterone therapy mitigates risk of cardiovascular event and improves measures of body habitus and can be considered as an adjuvant therapy for weigh loss. Pre-treatment with testosterone seems promising to improve the success of In-vitro Fertilization (IVF) in patients with ovarian failure. Transdermal testosterone use by postmenopausal woman does not influence mammographic density leading to probable misdiagnoses. The only evidence-based indication for testosterone therapy for women is for the treatment of Hypoactive Sexual Desire Disorder (HSDD). No female testosterone product has been approved by national regulatory authority due to the lack of data concerning efficacy and safety of these preparations in women. Copyright © 2023, Journal of Iranian Medical Council. All rights reserved. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Related Docs
View other Related Docs
1. The Effect of Vaginal Sildenafil on the Outcome of Assisted Reproductive Technology Cycles in Patients With Repeated Implantation Failures: A Randomized Placebo-Controlled Trial, International Journal of Fertility and Sterility (2020)
2. Can Testosterone Level Be a Good Predictor of Late-Onset Hypogonadism?, Andrologia (2015)
3. Does Prevalence of Female Sexual Dysfunction Differ Among Infertile Patients With or Without Polycystic Ovary Syndrome: A Cross-Sectional Study, International Journal of Fertility and Sterility (2024)
Experts (# of related papers)
View all Related Experts
Ladan Kashani (4)
Ashraf Moini (4)
Other Related Docs
4. Letrozole As Co-Treatment Agent in Ovarian Stimulation Antagonist Protocol in Poor Responders: A Double-Blind Randomized Clinical Trial, International Journal of Reproductive BioMedicine (2019)
5. Efficacy of Pharmacological and Non-Pharmacological Interventions on Low Sexual Interest/Arousal of Peri- and Post-Menopausal Women: A Meta-Analysis, Sexual and Relationship Therapy (2019)
6. Differential Expression of Mir-93 and Mir-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating With Different Phenotypes, Scientific Reports (2017)
7. Early Administration of Gonadotropin-Releasing Hormone Antagonist Versus Flexible Antagonist Ovarian Stimulation Protocol in Poor Responders: A Randomized Clinical Trial, Middle East Fertility Society Journal (2021)
8. The Effect of Methyltestosterone on in Vitro Fertilization Outcomes: A Randomized Clinical Trial on Patients With Low Ovarian Response, Clinical and Experimental Reproductive Medicine (2024)
9. Infertility Treatments and Risk of Breast Benign Diseases: A Case‒Control Study, BMC Women's Health (2024)
10. Oocyte Quality and in Vitro Fertilization Outcome in Triggering With Gnrh Agonist Versus Hcg, Gazzetta Medica Italiana Archivio per le Scienze Mediche (2023)
11. The Effect of Aphrodite on Orgasm and Sexual Desire in Menopausal Women: A Randomized Clinical Trial, HAYAT (2016)
12. A Bibliometric Analysis of Testosterone Replacement Therapy Studies: Mapping the Scientific Landscape, Medical Journal of the Islamic Republic of Iran (2024)
13. Oral Contraceptives, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
14. Differences in and Correlates of Sexual Function in Infertile Women With and Without Polycystic Ovary Syndrome, International Journal of Fertility and Sterility (2021)
15. The Effect of Intrauterine Administration of Growth Hormone on Ivf Success Rate in Recurrent Implantation Failure Women: A Randomized Clinical Trial, Iranian Journal of Pharmaceutical Research (2024)
16. The Efficacy of Gonadotropin-Releasing Hormone (Gnrh) Agonist Before Frozen Embryo Transfer in Improving Pregnancy Outcome and Decreasing Miscarriage Rate in Hyperandrogenic Polycystic Ovary Syndrome Women: A Randomized Clinical Trial, Minerva Ginecologica (2020)
17. Sexual Dysfunction in Polycystic Ovarian Syndrome Patients, Journal of Obstetrics# Gynecology and Cancer Research (2024)
18. Pregnancy Outcome of “Delayed Start” Gnrh Antagonist Protocol Versus Gnrh Antagonist Protocol in Poor Responders: A Clinical Trial Study, International Journal of Reproductive BioMedicine (2017)
19. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial, Frontiers in Endocrinology (2020)
20. Controlled Ovarian Stimulation With R-Fsh Plus R-Lh Vs. Hmg Plus R-Fsh in Patients Candidate for Ivf/Icsi Cycles: An Rct, International Journal of Reproductive BioMedicine (2017)